XTX301 in Patients With Advanced Solid Tumors

Clinical trial NCT05684965 · RECRUITING

Trial details

NCT number: NCT05684965
Sponsor: Xilio Development, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-05-11
Primary completion: 2028-09-01
Enrollment: 358

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.